Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 21 Oct, 12:00 am
Northern Trust (NASDAQ: NTRS) is set to report its third-quarter 2026 earnings, with analysts projecting strong growth in both earnings per share and revenue. Key drivers for this anticipated growth include significant increases in projected net interest income and total fee inco
WISeSat.Space Holdings (NASDAQ: SAIQ) more than doubled following an update on satellite cybersecurity testing. Braze (NASDAQ: BRZE) surged 51.7% after Salesforce agreed to acquire the company for approximately $5.66 billion . Myriad Genetics (NASDAQ: MYGN) gained 31.6% after agr
Picard Medical (NYSE American: PMI) led the selected decliners, falling 32.2% amid continued volatility. Sea Limited (NYSE: SE) dropped 9.1% on trading volume exceeding four times its recent average. Leveraged inverse ETFs LABD (NYSE Arca: LABD) , BMNZ (NYSE Arca: BMNZ) and SMST
Iridium Communications (NASDAQ: IRDM) reported robust Q3 2026 results, with initial earnings per share of $0.98 significantly exceeding the $0.34 estimate. The company's revenue reached $245.70 million , surpassing the $236.30 million estimate. Despite differing figures, Iridium
Wall Street anticipates Moody's (NYSE: MCO) to report Q3 2026 earnings of $4.25 per share on revenue of approximately $2.08 billion . Key revenue drivers include demand for credit ratings and growth in Moody's Analytics, particularly from recurring subscriptions and AI tools, des
Investment firm Raymond James increased its price target for Rapport Therapeutics (NASDAQ: RAPP) to $86.00 , reflecting strong analyst confidence in the biopharmaceutical company. The upward revision follows positive Phase 2 clinical trial results for its lead candidate, RAP-219,
Heartland Express (NASDAQ: HTLD) reported third-quarter revenue and earnings below analysts’ estimates. Revenue declined 8.7% year over year, but the company returned to profitability with net income of $1.0 million . The operating ratio improved by 500 basis points to 98.7
United Airlines (NASDAQ: UAL) is set to report Q3 earnings with analyst estimates projecting $2.57 to $2.60 EPS and revenue around $17.90 billion . Despite resilient revenue growth, higher fuel costs and inflation are pressuring profits, leading to a 6.9% drop in EPS estimates. U
Piper Sandler upgraded Myriad Genetics (NASDAQ: MYGN) to Neutral from Underweight, setting a $5.00 price target. Myriad Genetics is selling its prenatal health testing business to Labcorp for $210.00 million in cash. This strategic divestiture is expected to improve Myriad Geneti
Citigroup maintains a Buy rating on Brunello Cucinelli (OTC: BCUCY) stock. Brunello Cucinelli raised its 2026 outlook following stronger-than-expected third-quarter sales. The company's market capitalization stands at approximately $6.41 billion . Brunello Cucinelli (OTC: BCUCY)
Earnings Beat: Dime Community Bancshares (NYSE: DCOM) reported earnings per share (EPS) of $0.91 , significantly surpassing analyst estimates. Robust Revenue Growth: The company achieved revenue of $135.30 million , exceeding market expectations and demonstrating strong year-over
Annaly Capital Management is set to report Q3 2026 earnings with Wall Street estimating $0.77 EPS and $637 million in revenue. Zacks forecasts $0.78 EPS, a 6.9% year-over-year increase, alongside significant growth in net interest income ( $545 million , up 97.6%) and net servici
H.C. Wainwright maintained a Buy rating for Rapport Therapeutics and significantly raised its price target from $40.00 to $66.00 . Rapport Therapeutics' lead drug candidate, RAP-219, showed positive Phase 2 trial results for acute bipolar mania, meeting its primary endpoint. Anal
MSCI (NYSE: MSCI) surpassed third-quarter 2026 earnings estimates with an adjusted EPS of $5.11 and revenue of $892 million . Growth was driven by a 12.4% rise in revenue and a 14.3% increase in adjusted EPS year-over-year, supported by recurring subscriptions and asset-based fee
Capital One Financial (NYSE: COF) is set to announce its Q3 2026 earnings on October 20, with analysts anticipating a mixed financial performance. Revenue growth is projected, driven by strong credit card activity, particularly a significant rise in interchange fees and net inter
Loop Capital Markets downgraded Braze (NASDAQ:BRZE) from Buy to Hold. Salesforce (NYSE:CRM) plans to acquire Braze for approximately $5.66 billion , offering $47.50 per share. Braze's stock surged over 50% , trading at $45.46 , reflecting the acquisition offer. Loop Capital Marke
Synchrony Financial (NYSE: SYF) reported strong Q3 2026 financial results, with both earnings per share of $2.68 and revenue of $4.91 billion surpassing analyst expectations. Despite the revenue beat, net profit declined year-over-year to $892 million due to higher operating cost
Headlines provided by Investing.com
